11.100
+0,00%
2026-10-19
Fundamental Analysis
74 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +278.3% | +104.6% | 3 / 3 | +76.2% | +13.83 pp | +12.57 pp | +12.8% | 1.61 | 6.63 | 287 | +76,2% | 50,9 | +505,1% | 6.63 | 9.13 | −27,3% |
| Pts | 12 | 12 | 12 | 12 | 12 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 11.100 (close price on 2026-10-19)EPS (TTM): 1.673
Financial charts
1.Revenue & growth
VND bn284Q2/26
1.Revenue & growth
VND bn284Q2/26
2.Profit & growth
VND bn57,5Q2/26
3.Profit mix (Penman)
VND bn137Q2/26
4.Margins & cost structure
%33.6%Q2/26
5.Returns & cash cycle
% · days7.3%Q2/26
6.Earnings quality & cash
VND bn183Q2/26
7.Asset structure
VND bn3.180Q2/26
8.Funding & debt health
VND bn · times3.180Q2/26
9.Revenue backlog
VND bn7,54Q2/26
10.Valuation
times · %8,1×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %719Q2/26
Adjusted EPS growth, latest quarter
328%
Average adjusted EPS growth, 3 quarters
121%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
60.0%
Source: vnstockData through Q2/26